Shear-induced platelet aggregation in aspirin-treated patients: Initial experience with the novel PlaCor PRT® device

Thrombosis Research

Volumn 130, Issue 5, 2012, Pages 753-758

  Würtz, Morten ^a   Hvas, Anne Mette ^a   Wulff, Lise N ^a   Kristensen, Steen D ^a   Grove, Erik L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antiplatelet drugs; Aspirin; Coronary artery disease; Platelet count; Platelet function tests

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; COLLAGEN; HJERDYL; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AGED; ARTICLE; BLOOD SAMPLING; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MONOTHERAPY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TURBIDIMETRY;

AGED; ASPIRIN; BLOOD PLATELETS; BLOOD SPECIMEN COLLECTION; COHORT STUDIES; FEMALE; HUMANS; MALE; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SHEAR STRENGTH;

EID: 84867578860     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.08.312     Document Type: Article

References (30)

1. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, and C.J. Murray Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 9524 May 27 2006 1747 1757
2. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, and M.V. Huisman Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis Arch Intern Med 167 15 Aug 13 2007 1593 1599
3. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, J.W. Jukema, and M.V. Huisman Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis Am Heart J 154 2 Aug 2007 221 231
4. G. Krasopoulos, S.J. Brister, W.S. Beattie, and M.R. Buchanan Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 7637 Jan 26 2008 195 198
5. E.L. Grove, and S.D. Kristensen Update on oral antiplatelet therapy: principles, problems and promises Future Cardiol 5 3 May 2009 247 258
6. E.L. Grove, R.F. Storey, and M. Wurtz Platelet function testing in atherothrombotic disease Curr Pharm Des Jun 19 2012 [Epub ahead of print]
7. C.W. Hamm, J.P. Bassand, and S. Agewall ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 23 Dec 2011 2999 3054
8. R.S. Wright, J.L. Anderson, and C.D. Adams ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 19 May 10 2011 1920 1959
9. G.J. Johnson, A.V. Sharda, G.H. Rao, M.H. Ereth, D.D. Laxson, and W.G. Owen Measurement of Shear-Activated Platelet Aggregate Formation in Non-Anticoagulated Blood: Utility in Detection of Clopidogrel-Aspirin-Induced Platelet Dysfunction Clin Appl Thromb Hemost 18 2 Mar 2012 140 149
10. M. Wurtz, E.L. Grove, and L.N. Wulff Patients With Previous Definite Stent Thrombosis Have a Reduced Antiplatelet Effect of Aspirin and a Larger Fraction of Immature Platelets JACC Cardiovasc Interv 3 8 Aug 2010 828 835
11. E.L. Grove, M. Wurtz, A.M. Hvas, and S.D. Kristensen Increased platelet turnover in patients with previous definite stent thrombosis J Thromb Haemost 9 7 Jul 2011 1418 1419
12. M. Wurtz, L.N. Wulff, E.L. Grove, S.D. Kristensen, and A.M. Hvas Influence of renal function and platelet turnover on the antiplatelet effect of aspirin Thromb Res 129 4 Apr 2012 434 440
13. L.O. Jensen, M. Maeng, and P. Thayssen Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark Am J Cardiol 105 11 Jun 1 2010 1513 1519
14. M. Cattaneo Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur Heart J 28 14 Jul 2007 1673 1675
15. C. Patrono, G. Ciabattoni, and E. Pinca Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects Thromb Res 17 3-4 Feb 1 1980 317 327
16. PRT 7000 Test Cartridge - Instructions for use 2009 Placor, Inc.
17. C. Patrono, and B. Rocca Drug insight: aspirin resistance-fact or fashion? Nat Clin Pract Cardiovasc Med 4 1 Jan 2007 42 50
18. W. Kuliczkowski, A. Witkowski, and L. Polonski Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 30 4 Feb 2009 426 435
19. E.L. Grove, A.M. Hvas, and H.L. Johnsen A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease Thromb Haemost 103 6 Jun 2010 1245 1253
20. W.S. Nesbitt, E. Westein, and F.J. Tovar-Lopez A shear gradient-dependent platelet aggregation mechanism drives thrombus formation Nat Med 15 6 Jun 2009 665 673
21. G.J. Johnson, B.S. Schwartz, and L.A. Leis In vivo platelet retention in human bleeding-time wounds. I. Normal subjects and patients with platelet dysfunction J Lab Clin Med 94 4 Oct 1979 563 573
22. B.S. Schwartz, L.A. Leis, and G.J. Johnson In vivo platelet retention in human bleeding-time wounds. II. Effect of aspirin ingestion J Lab Clin Med 94 4 Oct 1979 574 584
23. T.D. Fahey, and R. Rolph Venous and capillary blood hematocrit at rest and following submaximal exercise Eur J Appl Physiol Occup Physiol 34 2 Apr 4 1975 109 112
24. N.H. Wallen, M. Ladjevardi, J. Albert, and A. Broijersen Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin Thromb Res 87 1 Jul 1 1997 151 157
25. M. Wurtz, A.M. Hvas, S.D. Kristensen, and E.L. Grove Platelet aggregation is dependent on platelet count in patients with coronary artery disease Thromb Res 129 1 Jan 2012 56 61
26. S.K. Kundu, E.J. Heilmann, R. Sio, C. Garcia, and R.A. Ostgaard Characterization of an In Vitro Platelet Function Analyzer, PFA-100 Clin Appl Thromb Hemost 2 1996 241 249
27. D. Varon, R. Dardik, and B. Shenkman A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions Thromb Res 85 4 Feb 15 1997 283 294
28. R.S. Alshameeri, and E.F. Mammen Performance characteristics and clinical evaluation of an in vitro bleeding time device-Thrombostat 4000 Thromb Res 79 3 Aug 1 1995 275 287
29. E.I. Peerschke, R.T. Silver, B. Weksler, S.E. Grigg, N. Savion, and D. Varon Ex vivo evaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and plate(let) analyzer: effect of platelet antagonists Br J Haematol 127 2 Oct 2004 195 203
30. G.V. Born, D. Bergquist, and K.E. Arfors Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes Nature 259 5540 Jan 22 1976 233 235